TORONTO, Aug. 25 /PRNewswire/ — Millennium Research Group
(MRG), the global authority on medical technology market
intelligence, finds that although venous procedures are set to grow
by more than 10% through 2013, a lack of awareness among referring
physicians is a major roadblock in increased interventions in the
venous system.
Despite this trend, specialists are increasingly adopting new
technologies, with 55% of respondents having used
pharmacomechanical thrombectomy systems for deep vein thrombosis
removal, and 66% performing venous stenting on a regular basis.
The venous system has recently been gaining exposure as an
under treated area of the human vasculature. New evidence of
clinical success has spurred a trend towards increasingly
aggressive interventions both for acute and chronic venous disease.
A major contributing factor was the 2008 Surgeon General’s Call
to Action on Deep Vein Thrombosis and Pulmonary Embolism, but
the rise of arterial stents in the venous system has also played a
significant role.
“Respondents identified increased education among primary care
practitioners as the most important factor that would drive venous
stenting,” says Stephanie LaBelle, Manager of the Cardiovascular
division at MRG. “A third of respondents were unaware of the
practice of venous stenting, and 40% do not refer patients for the
procedure.”
MRG’s new Physician Forum publication, Venous Interventions:
The Rise of Venous Stenting and Aggressive Deep Vein Thrombosis
Treatment is based on 98 US specialists who treat deep
vein diseases, and 78 primary care practitioners who refer these
patients. The publication investigates the changing dynamics
of the venous interventional market with a specific focus on acute
deep vein thrombosis treatment, and the treatment of obstructive
chronic deep vein disease with venous stents.
WebinarOn Wednesday September 8, at 11:00 am eastern time,
MRG is offering a comp
‘/>”/>
SOURCE
